科伦药业：注射用头孢唑林钠/氯化钠注射液获批

Core Viewpoint - Kolun Pharmaceutical (002422) announced that its subsidiary, Hunan Kolun Pharmaceutical Co., Ltd., has received drug registration approval from the National Medical Products Administration for its chemical drug "Cefazolin Sodium/Sodium Chloride Injection" [1] Group 1 - The drug is packaged in a dual-chamber bag, containing 1.0g of cefazolin and 0.9g of sodium chloride in 100ml of injection solution [1] - The dual-chamber bag design helps to avoid mismatching and contamination risks during the preparation process, making it suitable for rapid treatment in emergency situations [1] - Cefazolin sodium is a classic medication for infection treatment, with projected sales of 1.35 billion yuan for injection forms in China in 2024 [1] Group 2 - Kolun Pharmaceutical is the second company in China to receive approval for the dual-chamber bag packaging format [1]